3 Big Pharmas That Could be Winners for Investors in the Long Run Post author:Sam Post published:November 29, 2017 Post category:BioPharma Big pharma stocks have been longtime favorites among investors for several reasons. Source: BioSpace You Might Also Like Flagship Pioneering Secures $618M for Life Science Startup Mission December 19, 2017 How This Little Biopharma Could Beat Amgen, Teva to the Migraine Finish Line January 16, 2018 50+ Valeant Sales Reps May Have Jumped Ship to Synergy Pharma February 23, 2017
